For detailed information, please contact the employees of the Marketing Authorisation Branch.
Questions and answers relevant to pharmacovigilance and clinical trials are available from the respective sections.
The amended Act on Pharmaceuticals came into effect on 2 April 2013. We would like to summarize the major changes concerning marketing authorisations, pharmacovigilance and clinical trials, in the form of questions and answers.
For detailed information, please contact the employees of the Marketing Authorisation Branch.
Questions and answers relevant to pharmacovigilance and clinical trials are available from the respective sections.
2010 © SÚKL. Šrobárova 48, 100 41 Praha 10, +420 272 185 111, posta@suklcz.